HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatsuhiro Yoshiki Selected Research

gamma-Glutamylcyclotransferase

1/2018Prohibitin-2 is a novel regulator of p21WAF1/CIP1 induced by depletion of γ-glutamylcyclotransferase.
1/2018Depletion of gamma-glutamylcyclotransferase in cancer cells induces autophagy followed by cellular senescence.
1/2015Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatsuhiro Yoshiki Research Topics

Disease

19Neoplasms (Cancer)
07/2018 - 05/2002
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2018 - 04/2004
4Carcinoma (Carcinomatosis)
07/2015 - 11/2002
3Prostatic Neoplasms (Prostate Cancer)
01/2018 - 12/2002
3Transitional Cell Carcinoma
04/2004 - 05/2002
2Osteosarcoma (Osteogenic Sarcoma)
07/2018 - 04/2011
2Vesico-Ureteral Reflux (Vesicoureteral Reflux)
03/2014 - 10/2007
1Ovarian Neoplasms (Ovarian Cancer)
07/2018
1Glioma (Gliomas)
07/2018
1Breast Neoplasms (Breast Cancer)
09/2016
1Leukemia
12/2009
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
10/2007
1Neoplasm Metastasis (Metastasis)
10/2006
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2006
1Hypothermia
04/2004
1Lymphatic Metastasis
04/2004
1Fistula
09/2003
1Acute Cholecystitis
09/2003
1Pyonephrosis
09/2003
1Urinary Incontinence
09/2003
1Hemorrhage
09/2003
1Hepatocellular Carcinoma (Hepatoma)
11/2002
1Nonseminomatous germ cell tumor
11/2002
1Disease Progression
11/2002

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2002
6Tumor Biomarkers (Tumor Markers)IBA
04/2011 - 11/2002
4Messenger RNA (mRNA)IBA
03/2014 - 11/2002
3EnzymesIBA
07/2018 - 11/2002
3gamma-GlutamylcyclotransferaseIBA
01/2018 - 01/2015
3ProteomeIBA
07/2015 - 05/2004
3UroplakinsIBA
03/2014 - 01/2003
3CalreticulinIBA
05/2009 - 05/2004
2Glutathione (Reduced Glutathione)IBA
07/2018 - 11/2013
2Biomarkers (Surrogate Marker)IBA
07/2015 - 04/2011
2Uroplakin IaIBA
10/2007 - 05/2002
2Small Interfering RNA (siRNA)IBA
02/2007 - 04/2005
2Cisplatin (Platino)FDA LinkGeneric
02/2006 - 04/2004
2ImmunosorbentsIBA
12/2004 - 11/2002
1ProdrugsIBA
01/2018
1Cyclin-Dependent Kinases (cdk Proteins)IBA
09/2016
1Amino AcidsFDA Link
03/2015
1Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA
03/2015
1HeterochromatinIBA
10/2013
1geranylgeraniolIBA
12/2009
1Cytochromes c (Cytochrome c)IBA
12/2009
1Uroplakin IIIIBA
10/2007
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2007
1Etoposide (VP 16)FDA LinkGeneric
02/2006
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2006
1Monoclonal AntibodiesIBA
04/2005
1Thymidine PhosphorylaseIBA
04/2005
1Liposomes (Liposome)IBA
04/2005
1gamma-Synuclein (Persyn)IBA
12/2004
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
12/2004
1Protein Isoforms (Isoforms)IBA
12/2004
1IceIBA
04/2004
1Prostate-Specific Antigen (Semenogelase)IBA
12/2002
1AntibodiesIBA
12/2002
1Peptides (Polypeptides)IBA
11/2002
1Carrier Proteins (Binding Protein)IBA
11/2002
1Neoplasm Antigens (Tumor Antigens)IBA
11/2002
1AntigensIBA
11/2002
1LectinsIBA
11/2002
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2002

Therapy/Procedure

2Therapeutics
07/2018 - 11/2002
2Aftercare (After-Treatment)
12/2009 - 11/2002
2Drug Therapy (Chemotherapy)
10/2006 - 02/2006
2Cystectomy
04/2005 - 05/2002
2Nephrectomy
04/2004 - 09/2003
1Radiotherapy
10/2006
1Transplantation
02/2006
1Intravesical Administration
04/2005
1Lymph Node Excision (Lymph Node Dissection)
04/2004
1Combination Drug Therapy (Combination Chemotherapy)
04/2004
1Cholecystectomy
09/2003
1Prostatectomy (Retropubic Prostatectomy)
09/2003
1Immunotherapy
11/2002